View in EDS HTML Full Text PDF Full Text

Therapeutic approaches for the treatment of genetic and acquired cardiovascular calcification.

Saved in:
Bibliographic Details
Title: Therapeutic approaches for the treatment of genetic and acquired cardiovascular calcification.
Authors: O'Brien K; Research and Development, Inozyme Pharma, Boston, MA, United States., Husson H; Research and Development, Inozyme Pharma, Boston, MA, United States., Sabbagh Y; Research and Development, Inozyme Pharma, Boston, MA, United States.
Source: Frontiers in cardiovascular medicine [Front Cardiovasc Med] 2025 Oct 07; Vol. 12, pp. 1636432. Date of Electronic Publication: 2025 Oct 07 (Print Publication: 2025).
Publication Type: Journal Article; Review
Journal Info: Publisher: Frontiers Media S.A Country of Publication: Switzerland NLM ID: 101653388 Publication Model: eCollection Cited Medium: Print ISSN: 2297-055X (Print) Linking ISSN: 2297055X NLM ISO Abbreviation: Front Cardiovasc Med Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 41126916
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Therapeutic approaches for the treatment of genetic and acquired cardiovascular calcification.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22O'Brien+K%22">O'Brien K</searchLink>; Research and Development, Inozyme Pharma, Boston, MA, United States.<br /><searchLink fieldCode="AU" term="%22Husson+H%22">Husson H</searchLink>; Research and Development, Inozyme Pharma, Boston, MA, United States.<br /><searchLink fieldCode="AU" term="%22Sabbagh+Y%22">Sabbagh Y</searchLink>; Research and Development, Inozyme Pharma, Boston, MA, United States.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101653388%22">Frontiers in cardiovascular medicine</searchLink> [Front Cardiovasc Med] 2025 Oct 07; Vol. 12, pp. 1636432. <i>Date of Electronic Publication: </i>2025 Oct 07 (<i>Print Publication: </i>2025).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Review
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Frontiers+Media+S%2EA%22">Frontiers Media S.A </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>101653388 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Print <i>ISSN: </i>2297-055X (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%222297055X%22">2297055X </searchLink><i>NLM ISO Abbreviation: </i>Front Cardiovasc Med <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41126916
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.3389/fcvm.2025.1636432
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 1636432
    Titles:
      – TitleFull: Therapeutic approaches for the treatment of genetic and acquired cardiovascular calcification.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: O'Brien K
      – PersonEntity:
          Name:
            NameFull: Husson H
      – PersonEntity:
          Name:
            NameFull: Sabbagh Y
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 07
              M: 10
              Text: 2025 Oct 07
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-print
              Value: 2297-055X
          Numbering:
            – Type: volume
              Value: 12
          Titles:
            – TitleFull: Frontiers in cardiovascular medicine
              Type: main
ResultId 1